Atricure Inc. buy Needham & Company LLC
Start price
13.01.25
/
50%
€29.29
Target price
13.01.26
€39.22
Performance (%)
7.05%
Price
16.10.25
€31.36
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL shows slight gains of 7.05%. This prediction currently runs until 13.01.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | 1.025% | 1.025% |
| iShares Core DAX® | -2.465% | 2.641% |
| iShares Nasdaq 100 | -2.812% | 3.120% |
| iShares Nikkei 225® | -0.345% | 6.386% |
| iShares S&P 500 | -2.640% | 1.894% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $40.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat